Samsara Biocapital targets $500m for fund

Samsara Biocapital is seeking to raise $500 million for its new fund, according to an SEC filing.

Samsara Biocapital is seeking to raise $500 million for its new fund, according to an SEC filing. Based in Palo Alto, California, Samsara Biocapital invests in biotech innovation.

Source: SEC filing